Australia has reaped the rewards of outreach efforts on biosimilars, according to the country’s GBMA off-patent industry association, with the market share enjoyed by biosimilar medicines rising significantly in the two years since Australia’s government issued a grant for educational activities. In future, the GBMA’s Biosimilar Awareness Week could be used as the model for a global biosimilars campaign backed by the IGBA.
Australia has seen significant benefits from educational activities on biosimilars, according to the country’s Generic and Biosimilar Medicines Association.
In the two years since Australia’s government issued a grant for educational activities, the GBMA said, “biosimilar medicines have seen an increase in uptake, from approximately 15.4% market share in 2018 to 23